iVeena Implant May One Day Spare Macular Degeneration Patients the Pain of Eye Injections
August 10, 2011
It was recently reported that Dr. Balamurali Ambati, a clinical doctor and researcher at the Moran Eye Center, has developed a new device to deliver medication to the eyes of patients suffering from macular degeneration and glaucoma that may one day obviate the need for eye injections.
The iVeena device is a tiny, clear horseshoe-shaped ring that can be implanted in the area behind the eye’s lens during cataract surgery, and holds a reservoir of medication, which passes through a time-release membrane and can deliver eye medication for 6 to 12 months. Using a small incision, the iVeena device can be “recharged” with new medicine through a needle and small valve.
Now being commercialized, the device could be available within 5 years, and make eye injections a thing of the past.
Click here to read more about this new technology.
Comments
Jump down to form below to submit your own comments
